| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |